218 related articles for article (PubMed ID: 24823724)
1. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease.
Pulai S; Biswas A; Roy A; Guin DS; Pandit A; Gangopadhyay G; Ghorai PK; Sarkhel S; Senapati AK
Neurol India; 2014; 62(2):153-8. PubMed ID: 24823724
[TBL] [Abstract][Full Text] [Related]
2. Wilson's disease: a great masquerader.
Soltanzadeh A; Soltanzadeh P; Nafissi S; Ghorbani A; Sikaroodi H; Lotfi J
Eur Neurol; 2007; 57(2):80-5. PubMed ID: 17179709
[TBL] [Abstract][Full Text] [Related]
3. Brain magnetic resonance spectroscopy (MRS) as a diagnostic tool for detecting early neurological changes in children with Wilson's disease.
Alkhalik Basha MA; Refaat R; Ahmed AF; Yousef HY; Alsowey AM; Metwally MI; Aly SA; Hussien HM; El-Saadany HF; AlGhobashy AA; Talat MA; Amer MM; Eid AM
Eur J Radiol; 2019 Feb; 111():41-46. PubMed ID: 30691663
[TBL] [Abstract][Full Text] [Related]
4. Metabolic changes in 37 newly diagnosed Wilson's disease patients assessed by magnetic resonance spectroscopy.
Tarnacka B; Szeszkowski W; Gołebiowski M; Członkowska A
Parkinsonism Relat Disord; 2009 Sep; 15(8):582-6. PubMed ID: 19346156
[TBL] [Abstract][Full Text] [Related]
5. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
Tarnacka B; Szeszkowski W; Golebiowski M; Czlonkowska A
Mov Disord; 2008 Aug; 23(11):1560-6. PubMed ID: 18546325
[TBL] [Abstract][Full Text] [Related]
6. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.
Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A
Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Wilson's disease motor complications with deep brain stimulation.
Hedera P
Ann N Y Acad Sci; 2014 May; 1315():16-23. PubMed ID: 24547944
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates.
Prashanth LK; Sinha S; Taly AB; A Mahadevan ; Vasudev MK; Shankar SK
J Neurol Sci; 2010 Apr; 291(1-2):44-51. PubMed ID: 20116809
[TBL] [Abstract][Full Text] [Related]
9. Role of diffusion weighted magnetic resonance imaging and spectroscopy in the diagnosis and follow-up of hepatolenticular degeneration.
Xue P; Liu Y; Ma XH; Chen Y; Zhang SJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):497-502. PubMed ID: 23134827
[TBL] [Abstract][Full Text] [Related]
10. Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100 cases.
Prashanth LK; Sinha S; Taly AB; Vasudev MK
Mov Disord; 2010 Apr; 25(6):672-8. PubMed ID: 20437536
[TBL] [Abstract][Full Text] [Related]
11. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
[TBL] [Abstract][Full Text] [Related]
12. Structural and neurochemical evaluation of the brain and pons in patients with Wilson's disease.
Algin O; Taskapilioglu O; Hakyemez B; Ocakoglu G; Yurtogullari S; Erer S; Parlak M
Jpn J Radiol; 2010 Nov; 28(9):663-71. PubMed ID: 21113750
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
[TBL] [Abstract][Full Text] [Related]
14. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
15. Cranial MR imaging in Wilson's disease.
King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
[TBL] [Abstract][Full Text] [Related]
16. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI.
da Costa Mdo D; Spitz M; Bacheschi LA; Leite CC; Lucato LT; Barbosa ER
Neuroradiology; 2009 Oct; 51(10):627-33. PubMed ID: 19479249
[TBL] [Abstract][Full Text] [Related]
17. Correlation between neuroimaging, neurological phenotype, and functional outcomes in Wilson's disease.
Moura J; Pinto C; Freixo P; Alves H; Ramos C; Santos Silva E; Nery F; Gandara J; Lopes V; Ferreira S; Presa J; Ferreira JM; Miranda HP; Magalhães M
Neurol Sci; 2024 Jul; 45(7):3201-3208. PubMed ID: 38291197
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment and magnetic resonance imaging correlations in Wilson's disease.
Frota NA; Barbosa ER; Porto CS; Lucato LT; Ono CR; Buchpiguel CA; Caramelli P
Acta Neurol Scand; 2013 Jun; 127(6):391-8. PubMed ID: 23215772
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
